IL-18 may be adopted as one of the important biological markers to judge the disease of AAV, and the cumulative survival rate of patients with high NLR is low, which may be applied as an indicator to evaluate the poor prognosis of patients with AAV. This evidence concerns the gene IL18 and anti-neutrophil cytoplasmic antibody-associated vasculitis.